MedTrace Logo

Initiative for Patient Outcomes in Dialysis - Peritoneal Dialysis (PD) (IPOD-PD Study)

NCT01285726 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1092

Last updated 2016-05-02

No results posted yet for this study

Summary

The aim of the study is to asses the hydration status of incident peritoneal dialysis (PD) patients and its evolution over a period of four years, independent of the PD treatment modality (APD or CAPD) and the PD solution type.

Conditions

  • Chronic Renal Failure

Interventions

OTHER

Non-interventional study

This is a purely non-interventional, observational study, where treatment decisions are completely guided by the discretion of the attending nephrologists.

Sponsors & Collaborators

  • Fresenius Medical Care Deutschland GmbH

    lead INDUSTRY

Principal Investigators

  • Claudio Ronco, Prof · Ospedale San Bartolo

  • Wim Van Biesen, Prof · University Hospital, Ghent

  • Christian Verger, Dr · French Language PD Registry (RDPLF)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Austria
  • Belgium
  • Bosnia and Herzegovina
  • Brazil
  • Croatia
  • Cuba
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • India
  • Israel
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Norway
  • Portugal
  • South Korea
  • Spain
  • Sweden
  • Switzerland
  • Turkey (Türkiye)
  • United Kingdom
  • Venezuela

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01285726 on ClinicalTrials.gov